Cargando…

A Quantitative In Vitro Potency Assay for Adeno-Associated Virus Vectors Encoding for the UGT1A1 Transgene

Potency assessment of clinical-grade vector lots is crucial to support adeno-associated virus (AAV) vector release and is required for future marketing authorization. We have developed and validated a cell-based, quantitative potency assay that detects both transgenic expression and activity of an A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aronson, Sem J., Bakker, Robert S., Moenis, Sascha, van Dijk, Remco, Bortolussi, Giulia, Collaud, Fanny, Shi, Xiaoxia, Duijst, Suzanne, ten Bloemendaal, Lysbeth, Ronzitti, Giuseppe, Muro, Andrés F., Mingozzi, Federico, Beuers, Ulrich, Bosma, Piter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327880/ https://www.ncbi.nlm.nih.gov/pubmed/32637454 http://dx.doi.org/10.1016/j.omtm.2020.06.002

Ejemplares similares

Efficacy of AAV8-hUGT1A1 with Rapamycin in neonatal, suckling, and juvenile rats to model treatment in pediatric CNs patients
por: Shi, Xiaoxia, et al.
Publicado: (2020)

Low efficacy of recombinant SV40 in Ugt1a1(-/-) mice with severe inherited hyperbilirubinemia
por: Shi, Xiaoxia, et al.
Publicado: (2021)

A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome
por: Ronzitti, Giuseppe, et al.
Publicado: (2016)

Long-Term Effects of Biliverdin Reductase a Deficiency in Ugt1(−/−) Mice: Impact on Redox Status and Metabolism
por: Bortolussi, Giulia, et al.
Publicado: (2021)

Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome
por: Collaud, Fanny, et al.
Publicado: (2018)

Adeno-Associated Viral Vector Serotype 5 Poorly Transduces Liver in Rat Models
por: Montenegro-Miranda, Paula S., et al.
Publicado: (2013)

A novel UGT1A1 gene mutation causing severe unconjugated hyperbilirubinemia: a case report
por: Shi, Xiaoxia, et al.
Publicado: (2019)

Reduced spontaneous itch in mouse models of cholestasis
por: Langedijk, Jacqueline, et al.
Publicado: (2021)

Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler–Najjar Syndrome
por: Aronson, Sem J., et al.
Publicado: (2019)

Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivo
por: van Dijk, Remco, et al.
Publicado: (2017)

Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
por: Ronzitti, Giuseppe, et al.
Publicado: (2020)

Cre Recombinase Mediates the Removal of Bacterial Backbone to Efficiently Generate rSV40
por: Shi, Xiaoxia, et al.
Publicado: (2018)

Inflammatory signature of cerebellar neurodegeneration during neonatal hyperbilirubinemia in Ugt1(-/-) mouse model
por: Vodret, Simone, et al.
Publicado: (2017)

Generation of Ugt1-Deficient Murine Liver Cell Lines Using TALEN Technology
por: Porro, Fabiola, et al.
Publicado: (2014)

Long-term correction of ornithine transcarbamylase deficiency in Spf-Ash mice with a translationally optimized AAV vector
por: De Sabbata, Giulia, et al.
Publicado: (2020)

Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based Therapeutics
por: Barbon, Elena, et al.
Publicado: (2016)

Activation of Alternative Bilirubin Clearance Pathways Partially Reduces Hyperbilirubinemia in a Mouse Model Lacking Functional Ugt1a1 Activity
por: Banerjee, Bhaswati, et al.
Publicado: (2022)

Capsid-specific removal of circulating antibodies to adeno-associated virus vectors
por: Bertin, Berangere, et al.
Publicado: (2020)

Role of Regulatory T Cell and Effector T Cell Exhaustion in Liver-Mediated Transgene Tolerance in Muscle
por: Poupiot, Jérôme, et al.
Publicado: (2019)

Lethality rescue and long-term amelioration of a citrullinemia type I mouse model by neonatal gene-targeting combined to SaCRISPR-Cas9
por: Lisjak, Michela, et al.
Publicado: (2023)

Adeno-Associated Viral Vectors at the Frontier between Tolerance and Immunity
por: Mingozzi, Federico, et al.
Publicado: (2015)

Impairment of enzymatic antioxidant defenses is associated with bilirubin-induced neuronal cell death in the cerebellum of Ugt1 KO mice
por: Bortolussi, G, et al.
Publicado: (2015)

Real-Time Monitoring of Exosome Enveloped-AAV Spreading by Endomicroscopy Approach: A New Tool for Gene Delivery in the Brain
por: Orefice, Nicola Salvatore, et al.
Publicado: (2019)

Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor
por: Barbon, Elena, et al.
Publicado: (2021)

Autophagy determines efficiency of liver‐directed gene therapy with adeno‐associated viral vectors
por: Hösel, Marianna, et al.
Publicado: (2017)

Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction
por: Fitzpatrick, Zachary, et al.
Publicado: (2018)

Emerging Issues in AAV-Mediated In Vivo Gene Therapy
por: Colella, Pasqualina, et al.
Publicado: (2017)

The P4-ATPase ATP9A is a novel determinant of exosome release
por: Naik, Jyoti, et al.
Publicado: (2019)

Emerging Immunogenicity and Genotoxicity Considerations of Adeno-Associated Virus Vector Gene Therapy for Hemophilia
por: Monahan, Paul E., et al.
Publicado: (2021)

Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice
por: Famulari, Elvira Smeralda, et al.
Publicado: (2020)

Determination of Anti-Adeno-Associated Virus Vector Neutralizing Antibody Titer with an In Vitro Reporter System
por: Meliani, Amine, et al.
Publicado: (2015)

Serum Bilirubin Levels and Promoter Variations in HMOX1 and UGT1A1 Genes in Patients with Fabry Disease
por: Jirásková, Alena, et al.
Publicado: (2017)

The impact of minimally oversized adeno-associated viral vectors encoding human factor VIII on vector potency in vivo
por: Kyostio-Moore, Sirkka, et al.
Publicado: (2016)

Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients
por: Romero-Lorca, Alicia, et al.
Publicado: (2015)

Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase
por: Cagin, Umut, et al.
Publicado: (2020)

Correction: Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients
Publicado: (2015)

Differences in UGT1A1, UGT1A7, and UGT1A9 Polymorphisms between Uzbek and Japanese Populations
por: Maeda, Hiromichi, et al.
Publicado: (2014)

Historia de la UGT.
Publicado: (2008)

Predicting Flavonoid UGT Regioselectivity
por: Jackson, Rhydon, et al.
Publicado: (2011)

Adeno-Viren
por: Falke, Dietrich
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_a59gns2jfl4l3r7e5ccuc7r05r